- ECG within 10 minutes of chest pain. STEMI or equivalent → activate the cath lab.
- Primary PCI: first medical contact → device ≤90 min (≤120 min if transfer).
- PCI not possible in 120 min → fibrinolysis ≤30 min (tenecteplase), then transfer for cath within 2–24 h.
- Aspirin 162–325 mg chewed + P2Y12 (ticagrelor or prasugrel) + heparin.
- High-intensity statin. LDL goal <70, consider <55 (2025).
- Avoid nitrates in RV infarct, hypotension, or recent PDE-5 inhibitor.
Pathophysiology in 60 seconds
⌄
- Plaque ruptures or erodes → platelet + fibrin thrombus → complete occlusion of an epicardial artery → transmural ischemia → ST elevation.
- "Time is muscle": necrosis spreads from endocardium to epicardium over ~3–6 h.
- The goal is not the ECG — it is the occluded artery (the "OMI" concept). Some occlusions do not meet STE criteria.
Unstable anginaECG: ± ST↓ / T invTroponin: normal
NSTEMIECG: ± ST↓ / T invTroponin: ↑ with rise/fall
STEMIECG: ST↑ or equivalentTroponin: ↑ (do not wait)
One disease (plaque rupture → thrombus), three faces. Ischemia grows left → right. STEMI = total occlusion → open the artery now.
Diagnosis
⌄
Schematic drawing · 25 mm/s · 10 mm/mV · swipe ↔
| Leads | Threshold (new STE at J point) |
|---|---|
| V2–V3 | ≥2 mm men ≥40 · ≥2.5 mm men <40 · ≥1.5 mm women |
| All other leads | ≥1 mm |
| STEMI equivalents | Look for |
|---|---|
| Posterior MI | ST depression V1–V3 (tall R) → posterior leads V7–V9 ≥0.5 mm |
| LBBB / paced | Smith-modified Sgarbossa: concordant STE ≥1 mm, concordant STD V1–V3, or discordant STE/S ratio ≥25% |
| de Winter T waves | Upsloping STD + tall symmetric T in precordial leads (proximal LAD) |
| aVR elevation + diffuse STD | Left main / 3-vessel ischemia (or global subendocardial) |
| Wellens (pain-free) | Deep or biphasic T in V2–V3 → critical LAD; do not stress test |
| Inferior STE | Get V4R (RV infarct: STE ≥1 mm) |
Pericarditis · early repolarization · LVH · LV aneurysm · hyperkalemia · Brugada · Takotsubo · LBBB. Compare with old ECGs and repeat every 15–30 min.
Management
⌄
- Aspirin 162–325 mg chewed → 81 mg daily.
- P2Y12: ticagrelor 180 mg → 90 mg BID, or prasugrel 60 mg → 10 mg daily (avoid with prior stroke/TIA; 5 mg if <60 kg; generally not ≥75 y). Clopidogrel 600 mg if lytics or high bleed risk.
- Anticoagulant: UFH 70–100 U/kg bolus (in lab per protocol).
- O₂ only if SpO₂ <90%. Nitroglycerin SL for pain (not in RV MI/hypotension/PDE-5). Opioid if needed.
- High-intensity statin (atorvastatin 80 mg).
- Primary PCI preferred. Radial access.
- Lytic (tenecteplase weight-based) if PCI >120 min away and symptoms <12 h. Then cath 2–24 h; rescue PCI if failed (STE <50% resolution at 60–90 min).
- Non-culprit lesions: complete revascularization in stable patients (staged or same procedure) — not in cardiogenic shock (culprit-only).
- DAPT 12 months (most). High bleeding risk → shorter DAPT / de-escalation (e.g., ticagrelor monotherapy after 1 month).
- β-blocker if EF ≤40%, angina, arrhythmia. Routine BB in preserved EF after full revascularization: benefit uncertain (REDUCE-AMI, REBOOT).
- ACEi/ARB if EF ≤40%, HTN, DM, CKD. MRA if EF ≤40% + HF or DM.
- LDL goal <70 (consider <55): statin → add ezetimibe → PCSK9 inhibitor.
- Cardiac rehab referral. Smoking cessation.
- LV thrombus risk (large anterior MI) → echo; anticoagulate if thrombus.
Complications timeline
⌄
| When | Complication | Clue |
|---|---|---|
| Hours | VF/VT, AV block, cardiogenic shock | Telemetry |
| Days 2–7 | Papillary muscle rupture (acute MR) | New murmur, flash edema |
| Days 3–5 | VSR | Holosystolic murmur, step-up O₂ sat RA → RV |
| Days 5–14 | Free wall rupture | Sudden tamponade, PEA |
| Days 1–3 | Peri-infarct pericarditis | Pleuritic pain, rub |
| Weeks | Dressler syndrome, LV aneurysm (persistent STE), LV thrombus |
Board corner
⌄
| Stem | Answer |
|---|---|
| Inferior STEMI, BP 80/50 after nitro, clear lungs | RV infarct → fluids, no nitrates |
| ST depression V1–V3, tall R in V2 | Posterior MI → V7–V9 |
| Pain-free, deep T inversions V2–V3 | Wellens → cath, no stress test |
| Nearest PCI 3 h away, onset 2 h ago | Fibrinolysis, then transfer |
| Prasugrel in patient with prior stroke | Contraindicated |
| Day 5, sudden PEA arrest | Free wall rupture |
References
⌄
- Rao SV, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for ACS. Circulation / JACC. 2025.
- Thygesen K, et al. Fourth Universal Definition of MI. Circulation. 2018;138:e618.
- Smith SW, et al. Modified Sgarbossa criteria. Ann Emerg Med. 2012.